Inside the Verve Therapeutics offices (Kyle LaHucik for Endpoints News)

Verve snags $60M from Lil­ly to tack­le Lp(a) with one-time gene edit­ing

Eli Lil­ly has tapped an­oth­er gene edit­ing part­ner, this time look­ing to go af­ter a large pa­tient pop­u­la­tion in the car­dio­vas­cu­lar space with the help …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.